Travere Therapeutics, Inc. Common Stock
TVTXTravere Therapeutics, Inc. (TVTX) is a biotechnology company focused on developing and commercializing therapies for rare andимmunologic diseases. The company's portfolio includes treatments aimed at addressing unmet medical needs in kidney, liver, and rare neurological disorders. Founded with a mission to improve patient outcomes, Travere leverages its expertise in novel drug discovery and development to bring targeted therapies to market.
Company News
The American Kidney Fund hosted its third annual Patient Access Initiative Summit focusing on innovative kidney care technologies, AI applications, and addressing barriers to kidney disease prevention and treatment.
Multiple health care stocks experienced significant options trading activity, with various bullish and bearish signals across different companies in the sector.
Travere (TVTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
A mixed trial could hurt a kidney drug's chances of full approval.
Travere Therapeutics and Vera Therapeutics are also developing treatments for rare kidney disease
